Methylcobalamin is the methylated, biologically active form of vitamin B12 (CAS 13422-55-4, molecular weight 1,344.38 g/mol) that serves as the cofactor for cytosolic methionine synthase, the enzyme that transfers a methyl group from 5-methyltetrahydrofolate to homocysteine to produce methionine. Along with 5'-deoxyadenosylcobalamin — the cofactor for mitochondrial methylmalonyl-CoA mutase — it is one of only two cobalamin coenzyme forms known to be used by human enzymes. This article summarizes the coordination chemistry, enzymology, published in-vitro literature, and laboratory handling considerations relevant to methylcobalamin as a research compound. All information is provided strictly for in-vitro and laboratory research use only.
What Is Methylcobalamin?
Cobalamins are cobalt-containing corrinoids: a cobalt ion held in a substituted corrin macrocycle, with a lower (alpha) axial position typically occupied by a dimethylbenzimidazole nucleotide tail and an upper (beta) axial position occupied by a variable ligand. That upper ligand defines the form. In methylcobalamin (MeCbl) it is a methyl group bound directly to cobalt through a cobalt–carbon bond; in adenosylcobalamin (AdoCbl) it is a 5'-deoxyadenosyl group; in cyanocobalamin (CNCbl) a cyanide ion; and in hydroxocobalamin (OHCbl) a hydroxide.
The cobalt–carbon bond in alkylcobalamins is organometallic and unusually weak — reported bond dissociation energies fall below roughly 30 kcal/mol — which is precisely what makes these molecules useful as biological methyl- and radical-transfer cofactors, and also what makes them chemically fragile in the laboratory.
Methylcobalamin versus cyanocobalamin
Because MeCbl and AdoCbl are the forms that enzymes actually use, they are sometimes described as intrinsically superior to CNCbl. The biochemical literature does not support that framing as a general rule. Mammalian cells do not load dietary cobalamin directly onto apoenzymes; all incoming forms converge on a common cob(II)alamin intermediate before the coenzyme forms are re-synthesized in situ. Obeid, Fedosov, and Nexo reviewed this question in Molecular Nutrition & Food Research (2015) and concluded that the coenzyme forms are not likely to be superior to cyano- or hydroxocobalamin in preventing or correcting cobalamin deficiency. For laboratory work, the more relevant distinctions between forms are stability, light sensitivity, spectroscopic signature, and whether an assay is sensitive to the identity of the upper axial ligand.
Intracellular Processing: The MMACHC Step
The reason the "active form" argument does not hold up cleanly is the cytosolic chaperone MMACHC (the cblC gene product). Kim and colleagues showed in the Journal of Biological Chemistry (2009) that MMACHC performs two chemically distinct reactions depending on the substrate: reductive decyanation of cyanocobalamin, and a glutathione-dependent dealkylation of alkylcobalamins in which the glutathione thiolate displaces the alkyl group from cobalt, generating cob(I)alamin and the corresponding glutathione thioether. Notably, other biologically abundant thiols such as cysteine and homocysteine could not substitute for glutathione in that reaction.
The practical consequence for cell-based experiments is that MeCbl added to culture medium is not delivered intact to methionine synthase. It is stripped at MMACHC and the methyl group is re-installed downstream. Experimental designs that assume direct cofactor delivery — or that attribute an observed effect to the methyl group of the added compound — should account for this processing step.
The Two Human B12-Dependent Enzymes
Mascarenhas and colleagues reviewed the enzymology of both human cobalamin enzymes in Methods in Enzymology (2022).
Methionine synthase (MTR)
Methionine synthase uses MeCbl and catalyzes methyl transfer from 5-methyltetrahydrofolate to homocysteine. The cofactor shuttles between Co(III) and Co(I) oxidation states: methylcobalamin donates its methyl group to homocysteine, yielding methionine and enzyme-bound cob(I)alamin, which is then remethylated by methyltetrahydrofolate. Cob(I)alamin is a strong nucleophile and is occasionally oxidized to inactive cob(II)alamin — reported at roughly once per 2,000 catalytic turnovers — after which the enzyme requires reductive reactivation using an electron from reduced flavodoxin (or methionine synthase reductase in mammals) and a methyl group from S-adenosylmethionine.
Mendoza et al. reported the first high-resolution full-length structure of a cobalamin-dependent methionine synthase in Nature Communications (2023), using a thermophilic homolog and capturing cofactor loading in crystallo. Their work also described the apoenzyme state and rearrangements around the catalytic histidine (His761) upon cobalamin incorporation, which is directly relevant to any in-vitro assay that reconstitutes the holoenzyme from purified apoprotein plus cofactor.
Methylmalonyl-CoA mutase (MMUT)
The mitochondrial enzyme uses AdoCbl, not MeCbl, and catalyzes the 1,2 rearrangement of methylmalonyl-CoA to succinyl-CoA — the step that funnels propionyl-CoA from odd-chain fatty acids, branched-chain amino acids, and cholesterol side-chain catabolism into the TCA cycle. This is a radical-based reaction initiated by homolysis of the cobalt–carbon bond, mechanistically distinct from the heterolytic methyl transfer of methionine synthase. Because the two enzymes sit in different compartments and use different cofactor forms, methylmalonic acid and total homocysteine behave as partially independent readouts of cobalamin-dependent flux in cell and tissue models.
Photolability: The Handling Issue That Matters Most
Alkylcobalamins are photosensitive, and this is not a minor caveat — it is the dominant source of preventable artifact in methylcobalamin work.
Studies of the excited-state dynamics of MeCbl have characterized Co–C bond scission in detail. Photodissociation proceeds through low-lying excited states to a singlet-born methyl radical/cob(II)alamin radical pair, and the identity of the lower axial base modulates the branching between bond cleavage and nonradiative decay. Jarrett and colleagues reported in Bioorganic & Medicinal Chemistry (1996) that binding MeCbl to the methionine synthase apoenzyme slows photolysis roughly 50-fold, because hydrophobic residues on the upper face of the cofactor cage the methyl radical and favor recombination of the radical pair. Free methylcobalamin in solution has no such protection.
Practically, this means: work under subdued or filtered light, use amber vials or foil-wrapped containers, minimize open bench time, and avoid prolonged exposure of stock solutions to ambient fluorescent lighting. Aerobic photolysis of MeCbl converts it to hydroxocobalamin, so a preparation that has been light-exposed is no longer the compound the protocol specifies — even though it still reads as "cobalamin" by many detection methods. UV-visible spectroscopy is the simplest in-lab check: MeCbl and OHCbl have distinguishable absorption spectra, and a shift in the spectrum is a direct indicator of degradation.
What the In-Vitro Literature Reports
Most mechanistic cell-culture work on methylcobalamin has come out of neuroscience laboratories.
Okada et al. reported in Experimental Neurology (2010) that methylcobalamin at concentrations above 100 nM promoted neurite outgrowth and neuronal survival in culture, and that these effects were mediated through the methylation cycle rather than by cobalamin acting as a generic antioxidant — increased Erk1/2 and Akt phosphorylation were observed downstream. The methylation-cycle dependence is the useful methodological detail here, because it predicts that the effect should be sensitive to methionine and folate availability in the medium.
Nishimoto and colleagues reported in Frontiers in Cellular Neuroscience (2015) that MeCbl promoted Schwann cell differentiation in vitro, with downregulated Erk1/2 activity and increased myelin basic protein expression, and that myelination was promoted in a dorsal root ganglion neuron–Schwann cell coculture system.
In a motor neuron model, Ito et al. reported in NeuroReport (2017) that methylcobalamin dose-dependently prevented death of embryonic stem cell–derived motor neurons cocultured with astrocytes expressing mutant human SOD1 (G93A).
These are cell-culture and animal-model observations. They characterize the biochemical behavior of the compound in defined experimental systems and say nothing about outcomes in humans.
Current Research Context (2026)
Cobalamin chemistry remains an active field. The third installment of the Coordination Chemistry Reviews series on cobalt corrinoids — "Recent advances and emerging themes. Part 3. Cobalamins and health," published in 2026 — surveys recent developments across cobalamin physiology, the limitations of current biomarkers, corrinoid delivery chemistry, and microbiome-linked corrinoid metabolism. Two themes in that review are worth noting for researchers designing experiments: proposed activities of cobalamin derivatives beyond classical cofactor function, and the extent to which gut microbial corrinoid trafficking complicates interpretation of whole-organism cobalamin studies. Both suggest that in-vitro systems with defined cobalamin content remain valuable for isolating specific mechanisms.
Storage and Handling
Vitamin B12 (methylcobalamin) is supplied by Dynamite Research Peptides as a 10 ml solution at 99%+ purity, tested for endotoxin and sterility, with a Certificate of Analysis available per batch.
Recommended handling reflects the photochemistry described above:
- Store at -20°C, protected from light and moisture.
- Keep in amber or opaque containers, or wrap vials in foil.
- Limit light exposure during handling — measure and dilute under reduced lighting where practical.
- Avoid repeated freeze-thaw cycles; aliquot working volumes on first use.
- Verify identity spectroscopically if a preparation has been stored for an extended period or may have been light-exposed.
- Consult the batch Certificate of Analysis for purity, analytical data, and any batch-specific guidance.
Frequently Asked Questions
Q: Is methylcobalamin the same thing as vitamin B12?
A: Methylcobalamin is one specific form of vitamin B12. "Vitamin B12" is a collective term for the biologically relevant cobalamins, which include methylcobalamin, adenosylcobalamin, cyanocobalamin, and hydroxocobalamin. They share the same corrin-cobalt core and differ in the upper axial ligand bound to cobalt.
Q: Which enzyme uses methylcobalamin?
A: Methionine synthase (MTR), a cytosolic enzyme that methylates homocysteine to form methionine using 5-methyltetrahydrofolate as the methyl donor. The other human cobalamin-dependent enzyme, mitochondrial methylmalonyl-CoA mutase, uses adenosylcobalamin instead.
Q: Why is methylcobalamin so light-sensitive?
A: The cobalt–carbon bond is weak — below about 30 kcal/mol — and absorbs visible light readily, producing a methyl radical/cob(II)alamin radical pair. In solution, and particularly under aerobic conditions, this converts methylcobalamin to hydroxocobalamin. Protein binding suppresses this: methionine synthase slows the photolysis rate roughly 50-fold by caging the radical pair.
Q: Does methylcobalamin reach methionine synthase intact in cell culture?
A: No. The cytosolic chaperone MMACHC dealkylates alkylcobalamins in a glutathione-dependent reaction, producing cob(I)alamin, which is then re-methylated on the enzyme. Experimental interpretations that depend on direct delivery of the added methyl group should account for this.
Q: What form is this research compound supplied in?
A: A 10 ml solution at 99%+ purity, endotoxin- and sterility-tested, with a Certificate of Analysis available for each batch.
Summary
Methylcobalamin is a well-characterized organometallic cofactor with a defined enzymatic role in one-carbon metabolism, a documented intracellular processing pathway through MMACHC, and a well-studied photochemistry that dictates how it must be handled in the laboratory. The in-vitro literature describing effects on neurite outgrowth, Schwann cell differentiation, and motor neuron survival is mechanistically specific and tied to the methylation cycle. As with all cell-culture and animal findings, these observations describe the compound's behavior in experimental systems and do not extend to any human application.
All products are for research use only — not for human or animal consumption. Nothing on this page is a therapeutic claim, and no dosing, administration, or clinical guidance is provided or implied.